UCSF

ZINC04258316

Substance Information

In ZINC since Heavy atoms Benign functionality
November 16th, 2005 19 No

CAS Numbers: 446-86-6 , 55774-33-9 , [446-86-6]

Other Names:

1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-

1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-; 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; 6-((1-methyl-4-nitroimidazol-5-yl)thio)purine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine; 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin

1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-

446-86-6

446-86-6; Azasan (TN); Azathioprine (JP16/USP/INN); D00238; Imuran (TN)

446-86-6; Azathioprine; C06837

446-86-6; Azathioprine; CPD000427366; SAM002589938

446-86-6; Azathioprine; Prestwick_41

55774-33-9 (hydrochloride salt)

55774-33-9; Azathioprine sodium (USP); D03033; Imuran (TN)

56

6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine

6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine; 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine; Imuran (TN)

6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-9H-purine

6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine

6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine

6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine

6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine

6-(1-Methyl-4-nitroimidazol-5-ylthio)purin

6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]

6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine

6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine

6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine

6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine

6-(Methyl-p-nitro-5-imidazolyl)-thiopurine

6-(Methyl-p-nitro-5-imidazolyl)thiopurine

6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine

6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine

6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine

6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine

6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine

6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine

6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine

6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine

9H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-

A 4638

A2593_SIAL

A4638_SIAL

A4638_SIGMA

AB00443544

AB00443544-03

AC-4230

AC1L1DAL

AC1Q3Z1F

AI-981/34845012

AI3-50290

Azamun

Azamun [Czech]

Azanin

Azasan

Azasan (TN)

Azasan, Imuran, Azamun, BW-57-322, NSC-39084

Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine

Azathioprin

Azathioprin;Azatioprin;Azothioprine

Azathioprin;Azothioprine;Azatioprin

Azathioprine (Azasan, Imuran)

Azathioprine (BAN

Azathioprine (JP15/USP/INN)

Azathioprine Sodium

Azathioprine [USAN:INN:BAN:JAN]

Azathioprine; CPD000427366; SAM002589938

Azathioprinum

Azathioprinum [INN-Latin]

Azathiopurine

azatiopr in

Azatioprin

Azatioprina

Azatioprina [INN-Spanish]

Azothioprine

B. W. 57-322

BPBio1_000054

BRD-K32821942-001-05-6

BRD-K60324116-001-01-5

BSPBio_000048

BSPBio_001876

BW 57-322

BW 57322

BW-57-322

C06837

C9H7N7O2S

CAS-446-86-6

CBDivE_013132

CCRIS 62

Ccucol

CHEBI:2948

CHEMBL1542

ChemDiv1_002659

CID2265

cMAP_000046

CPD000427366

Cytostatics

D00238

DAP000782

DB00993

DivK1c_000586

EINECS 207-175-4

EU-0100027

FDA

FT-0083532

HMS1568C10

HMS1920E17

HMS2091K19

HMS501N08

HMS594I19

HSDB 7084

IDI1_000586

Immuran

Imuran

Imuran (TN)

Imurek

Imurel

INN

INN); Azathioprine Sodium (FDA

JAN

KBio1_000586

KBio2_000464

KBio2_002427

KBio2_003032

KBio2_004995

KBio2_005600

KBio2_007563

KBio3_001376

KBio3_002906

KBioGR_000646

KBioGR_002427

KBioSS_000464

KBioSS_002433

LS-123

Methylnitroimidazolylmercaptopurine

MFCD00055974

MFCD00069203

MLS001049307

MolPort-000-745-914

MolPort-000-764-262

MolPort-003-665-485

Muran

NCGC00015060-01

NCGC00015060-02

NCGC00015060-04

NCGC00015060-12

NCGC00090836-01

NCGC00090836-02

NCGC00090836-03

NCGC00090836-04

NCGC00090836-05

NCGC00090836-06

NCGC00094593-01

NCGC00094593-02

NCGC00094593-03

NCI-C03474

NINDS_000586

NSC 39084

NSC-39084

NSC39084

Oprea1_375441

Oprea1_533384

Oprea1_633462

Prestwick0_000094

Prestwick1_000094

Prestwick2_000094

Prestwick3_000094

Prestwick_41

Purine, 6-((1-methyl-4-nitroimidazol-5-yl)thio)-

Purine, 6-(1-methyl-4-nitro-5-imidazolylthio)-

Purine, 6-[(1-methyl-4-nitroimidazol-5-yl)thio]-

S1721_Selleck

SAM002589938

SDCCGMLS-0065415.P001

SMR000427366

SPBio_000255

SPBio_001987

SPECTRUM1500133

Spectrum2_000068

Spectrum3_000308

Spectrum4_000243

Spectrum5_000848

Spectrum_000064

STK831906

STOCK1S-20293

STOCK1S-27186

Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl)

UNII-MRK240IY2L

USAN

USP

USP)

USP); Azathioprine Sodium (FDA

WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW

ZINC04258316

[Methyl(nitroimidazolyl)mercaptopurine]

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 0.50 7.86 -28.67 1 9 0 118 277.269 3
Hi High (pH 8-9.5) 0.50 7.39 -51.02 0 9 -1 116 276.261 3

Vendor Notes

Note Type Comments Provided By
Molecular_Solubility 2.662 Bitter DB
ALOGPS_SOLUBILITY 1.07e+00 g/l DrugBank-approved
Purity 97% APIChem
Purity >95% Matrix Scientific
Indications antineoplastic, immunosuppressive KeyOrganics Bioactives
Patent Database Links EP0970694; EP0984012; EP1104760; EP1176140; EP1229034; EP1310488; EP1382339; EP1471054; EP1537858; EP1538164; EP1557173; EP1580188; EP1593386; EP1607103; EP1611879; EP1623721; EP1649857; EP1686130; EP1712220; EP1717247; EP1754472; EP1762248; EP1769807; EP ChEBI
therap immunosuppressant, antineoplastic, antirheumatic MicroSource Spectrum
Indications immunosuppressive KeyOrganics Bioactives
Warnings IRRITANT Matrix Scientific
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : A-3846; NCC_SUPPLIER_SAMPLE_COMMENTS : YELLOW POWDER NIH Clinical Collection via PubChem
Target Others Selleck Chemicals
Therapy Purine analog; purine synthesis inhibitor; immunosuppressant SMDC Iconix
Target Rho Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: A-3846; SUPPLIER_COMMENTS: YELLOW POWDER NIH Clinical Collection via PubChem

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
Z100081-3-O PBMC (Peripheral Blood Mononuclear Cells) (cluster #3 Of 4), Other Other 230 0.49 Functional ≤ 10μM
Z50425-15-O Plasmodium Falciparum (cluster #15 Of 22), Other Other 10000 0.37 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
Z100081 Z100081 PBMC (Peripheral Blood Mononuclear Cells) 230.4 0.49 Functional ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 10000 0.37 Functional ≤ 10μM

Analogs ( Draw Identity 99% 90% 80% 70% )

No pre-computed analogs available. Try a structural similarity search.